Arkolith/Insider Trading/GALT/Form 4

Jamil Khurram

Chief Medical OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jul 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$83K
Net Open-Market Flow
-$83K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2026Option exercise(M)16K$3.04$49K16K
Jul 14, 2026Sell(S)16K$5.13$83K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 14, 2026Option exercise(M)16K—$049K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000063) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for GALECTIN THERAPEUTICS INC

Build

Ask your agent about GALT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001133416-26-000063"
Ask your agent
Use Arkolith to summarize insider buying and selling at GALECTIN THERAPEUTICS INC
over the last 90 days and cite the filings.